The authors examined The National Cancer Database for patients who refused recommended surgery and elected stereotactic body radiation therapy (SBRT) for stage I/II non-small cell lung cancer.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer
July 10, 2020
May 29, 2020
This randomized controlled trial conducted by the National Emphysema Treatment Trial (NETT) on the results of lung volume reduction surgery (LVRS) was re-evaluated by the authors for longer-term results. They found long-term benefits to patients randomized to LVRS.
Complex Sleeve Lobectomy Has the Same Surgical Outcome When Compared With Conventional Lobectomy in Patients With Lung Cancer
May 8, 2020
This original article compares the outcome of sleeve lobectomy compared to conventional lobectomy in the treatment of patients with lung cancer. Inci et al. investigated 187 patients who underwent sleeve lobectomy and compared it to 568 patients who underwent conventional lobectomy.
April 27, 2020
This manuscript outlines the difficulties of providing safe thoracic surgery during COVID-19 and details solutions for overcoming these challenges.
Prognostic Factors Related to Postoperative Survival in the Newly Classified Clinical T4 Lung Cancer
April 21, 2020
This manuscript by Yamanashi et al retrospectively looks into the outcome of patients with newly classified clinical T4 lung cancer. They report 93 patients who underwent surgical treatment during a 10-year study period.
April 12, 2020
This video demonstrates a video-assisted thoracoscopic approach for left lung upper lobe anterior segment GGO.
April 10, 2020
The NCDB was queried to assess the optimal timing for resection after induction therapy for IIIA NSCLC. Survival was better in patients who underwent surgery in a short delay interval (<77 days) compared to a long delay (>114 days); short and medium delay intervals had similar outcomes.
March 24, 2020
A succinct comment with a wealth of up-to-date references vis-a-vis the SARS-CoV-2 pandemic.
March 23, 2020
This case report suggests that recurrent right pleural effusions could be a side effect of hepatic artery infusion pump chemotherapy in the treatment of metastatic colorectal cancer.
March 22, 2020
Leanne Harling, Doug Mathisen, and Erino Rendina share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.